Technology Transfer

Technology transfer is the process of transferring scientific findings from one organization to another for the purpose of furthering development and commercialization. Strong technology transfer policies, combined with robust patent protection, enable biotechnology companies to engage in partnering and ultimately secure the enormous financial resources needed to translate basic scientific discoveries into real-world solutions for disease, pollution, and hunger.

Thanks to the enduring effectiveness of the Bayh-Dole Act, American research universities, along with industry partners, are turning federally-funded basic research into new and valuable products that save and improve lives. The commercialization of university-based research to create new companies and good, high-paying jobs is a key driver of America’s innovation economy

Jim Greenwood

Former BIO President & CEO

BIO Toolkit Resources

The Successful Partnership of Publicly-Funded Research & Private Sector Innovation

The Bayh-Dole Act

U.S. Leadership in Biotechnology

Vaccine Development, Manufacturing and Distribution During a Pandemic

Biopharmaceutical Innovators are Leading the Charge in Fight Against Coronavirus

BIO Members are Working Round the Clock To Find Solutions to Combat Coronavirus

BIO Reports and Other Resources

The Economic Contribution of University/Nonprofit Inventions in the United States: 1996-2017

The Economic Contribution of University/Nonprofit Inventions in the United States: 1996-2015

BIO Report, Transforming Ideas into Advances: Best Practices in State and Regional Bioscience Economic Development Initiatives

TEConomy/BIO Report, Investment, Innovation and Job Creation in a Growing U.S. Bioscience Industry

Become an Advocate for Biotechnology

Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.

Join BIOAction